The lipid globotriaosylceramide promotes germinal center B cell responses and antiviral immunity
Science · 2024
DOI: 10.1126/science.adg0564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2024. Verfasst von Pankaj Sharma und 16 weiteren Autor:innen. Beteiligte Einrichtung: Program in Cellular and Molecular Medicine, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: B-Lymphocytes, Germinal Center, Trihexosylceramides, Orthomyxoviridae. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Influenza viruses escape immunity owing to rapid antigenic evolution, which requires vaccination strategies that allow for broadly protective antibody responses. We found that the lipid globotriaosylceramide (Gb3) expressed on germinal center (GC) B cells is essential for the production of high-affinity antibodies. Mechanistically, Gb3 bound and disengaged CD19 from its chaperone CD81, permitting CD19 to translocate to the B cell receptor complex to trigger signaling. Moreover, Gb3 regulated major histocompatibility complex class II expression to increase diversity of T follicular helper and GC B cells reactive with subdominant epitopes. In influenza infection, elevating Gb3, either endogenously or exogenously, promoted broadly reactive antibody responses and cross-protection. These data demonstrate that Gb3 determines the affinity and breadth of B cell immunity and has potential as a vaccine adjuvant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Program in Cellular and Molecular Medicine, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
- Program in Cellular and Molecular Medicine, Boston Children's Hospital, Department of Genetics, Harvard Medical School, The Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA, USA.
- Department of Biochemistry II, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Biomedical Sciences, Chubu University College of Life and Health Sciences, Kasugai, Japan.
- Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada.
ORCID-Profile: Pankaj Sharma, Kevin Ly, Yu Hu, Adam Yongxin Ye, Ji Hyung Kim, Chong Wang, Quinton Celuzza, David R Bundle, Koichi Furukawa, Frederick W Alt, Florian Winau
Förderung
- NIAID NIH HHS
- Howard Hughes Medical Institute
Zitieren
APA
Sharma, P., Zhang, X., Ly, K., Zhang, Y., Hu, Y., Ye, A. Y., Hu, J., Kim, J. H., Lou, M., Wang, C., Celuzza, Q., Kondo, Y., Furukawa, K., Bundle, D. R., Furukawa, K., Alt, F. W., & Winau, F. (2024). The lipid globotriaosylceramide promotes germinal center B cell responses and antiviral immunity. Science. https://doi.org/10.1126/science.adg0564
Vancouver
Sharma P, Zhang X, Ly K, Zhang Y, Hu Y, Ye AY, et al. The lipid globotriaosylceramide promotes germinal center B cell responses and antiviral immunity. Science. 2024. doi:10.1126/science.adg0564
BibTeX
@article{Sharma2024,
author = {Sharma, Pankaj and Zhang, Xiaolong and Ly, Kevin and Zhang, Yuxiang and Hu, Yu and Ye, Adam Yongxin and Hu, Jianqiao and Kim, Ji Hyung and Lou, Mumeng and Wang, Chong and Celuzza, Quinton and Kondo, Yuji and Furukawa, Keiko and Bundle, David R and Furukawa, Koichi and Alt, Frederick W and Winau, Florian},
title = {The lipid globotriaosylceramide promotes germinal center B cell responses and antiviral immunity},
journal = {Science},
year = {2024},
doi = {10.1126/science.adg0564}
}
EUVIMED